Halozyme Inks $1.5B Convertible Debt Deal and Capped Calls
Halozyme closed a $1.5B convertible debt offering with capped calls, refinancing 2027 and 2028 notes while securing over $630M in fresh liquidity.
capped calls
Halozyme closed a $1.5B convertible debt offering with capped calls, refinancing 2027 and 2028 notes while securing over $630M in fresh liquidity.